Alzheimer’s prevention hope as drug cuts deadly disease onset in half

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in people with a genetic predisposition to the devastating condition. Right now, symptoms are almost 100% likely to develop in patients between the ages of 30 and 65.

Continue Reading

Category: Alzheimer's & Dementia, Brain Health, Body & Mind

Tags: Washington University School of Medicine, Alzheimer's disease, Dementia, Genetics, Brain, Cognitive functioning, Disease, clinical trials


http://dlvr.it/TJfzTf

Popular Content

Leo Villareal launches Cosmic Bloom on Outland.art

Increasing Your Companys ROI: A Strategic Approach

Tesla's new Model Y arrives in the US

Review: Unitree Go2 Pro robot is fun on four legs – but it needs a purpose in life

Apple's AirPods Pro are back down to $180 on Amazon